NovoCure Limited revenue breakdown overview

NovoCure Limited revenue for the last year amounted to 605.22 M USD, the most of which — 605.22 M USD — came from its highest performing source at the moment, Tumor Treating Fields, the year earlier bringing 509.34 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought NovoCure Limited 391.80 M USD, and the year before that — 349.74 M USD.